Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Decazes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2020
[PET technology: Latest advances and potential impact on radiotherapy]P Decazes, S Hapdey, A Larnaudie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 6, 2020
Interest of positron-emission tomography and magnetic resonance imaging for radiotherapy planning and controlG Créhange, M Soussan, D Gensanne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 26, 2020
Benefits of positron emission tomography scans for the evaluation of radiotherapyP Decazes, S Thureau, R Modzelewski, et al.
Scientific Reports|May 21, 2021
Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLCR Mallet, P Decazes, R Modzelewski, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2019
["Definition of target volume: When et how can the radiation oncologist use PET?"]S Thureau, E Texte, P Decazes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 30, 2020
PET and MRI guided adaptive radiotherapy: Rational, feasibility and benefitS Thureau, A Briens, P Decazes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 9, 2020
Radiomics: A primer for the radiation oncologistJ-E Bibault, L Xing, P Giraud, et al.
Cancer Medicine|December 13, 2025
Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced-Stage Hodgkin LymphomaS Draye-Carbonnier, S-D Mihailescu, P Pinochet, et al.
Scientific Reports|April 5, 2024
Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphomaS Draye-Carbonnier, V Camus, S Becker, et al.
Hematological Oncology|December 16, 2024
Combining Total Metabolic Tumor Volume With Beta-2-Microglobulin Levels Predicts Outcomes in High-Burden Follicular Lymphoma PatientsA Zduniak, E Lévêque, S Draye-Carbonnier, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2020
[PET technology: Latest advances and potential impact on radiotherapy]P Decazes, S Hapdey, A Larnaudie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 6, 2020
Interest of positron-emission tomography and magnetic resonance imaging for radiotherapy planning and controlG Créhange, M Soussan, D Gensanne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 26, 2020
Benefits of positron emission tomography scans for the evaluation of radiotherapyP Decazes, S Thureau, R Modzelewski, et al.
Scientific Reports|May 21, 2021
Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLCR Mallet, P Decazes, R Modzelewski, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2019
["Definition of target volume: When et how can the radiation oncologist use PET?"]S Thureau, E Texte, P Decazes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 30, 2020
PET and MRI guided adaptive radiotherapy: Rational, feasibility and benefitS Thureau, A Briens, P Decazes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 9, 2020
Radiomics: A primer for the radiation oncologistJ-E Bibault, L Xing, P Giraud, et al.
Cancer Medicine|December 13, 2025
Prognostic Value of Massiveness Parameters Measured on Baseline FDG PET in Advanced-Stage Hodgkin LymphomaS Draye-Carbonnier, S-D Mihailescu, P Pinochet, et al.
Scientific Reports|April 5, 2024
Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphomaS Draye-Carbonnier, V Camus, S Becker, et al.
Hematological Oncology|December 16, 2024
Combining Total Metabolic Tumor Volume With Beta-2-Microglobulin Levels Predicts Outcomes in High-Burden Follicular Lymphoma PatientsA Zduniak, E Lévêque, S Draye-Carbonnier, et al.
Pageof 1